Catalyst Wire Dossier Catalyst Wire Dossier

Arginyl-fructose

arginyl-fructose
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Arginyl-fructose, covering 2014-11-06 to 2014-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Anti-hyperglycemic Effect of Short-term Arginyl-fructose Supplementation in Subjects With Pre-diabetes and Newly Diagnosed Type 2 Diabetes: Randomized, Double-blinded, Placebo-controlled Trial. [NA]

See pricing